ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 158

The Use Of “Autoantigenomics” To Rapidly Identify Targets Of Human Autoantibodies

Wei-Hong Yang1, Emily G. Bloch2, Daniel F. Berenson3, Rita L. Galdos3, Pankaj Arora4, Connie Wu2 and Donald B. Bloch5, 1Rheumatology, allergy and immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 2Anesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 3The Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 43the Center for Human Genetic Research and Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 5Rheumatology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Autoantigens and proteomics

  • Tweet
  • Email
  • Print
Session Information

Session Title: Genetics and Genomics of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Background/Purpose: The messenger RNA (mRNA) processing body (P-body) is a cellular structure that regulates the stability of cytoplasmic mRNA. Approximately 5% of patients with the autoimmune disease primary biliary cirrhosis (PBC) have antibodies directed against this structure and some patients have antibodies that react with several different known P-body components. In this study, we used a proteomic array and serum from a PBC patient to rapidly and efficiently identify a new P-body component.

Methods: Serum from patient 0081 was used to probe a high density protein macroarray which contains approximately 17,000 proteins. The proteins were produced in situ on a polyvinylidene difluoride (PVDF) membrane by Escherichia coli transformed with a prokaryotic expression cDNA library. This library was derived from mRNA prepared from phytohemagglutinin treated human T-lymphocytes. Human auto-antibodies that bound to the protein macroarray were detected using horse-radish peroxidase-conjugated rabbit anti-human IgG antiserum and chemiluminescence. Immunoreactive protein targets of these autoantibodies were determined by their locations on the PVDF membrane. Immunoblot was then used to confirm that serum 0081 contained antibodies that reacted with newly indentified autoantigens. Human epidermoid cancer cells (HEp-2 cells) were transfected with plasmids encoding green fluorescent protein (GFP) fused to the new P-body component candidates, to confirm that the proteins localized to P-bodies.

Results: Serum 0081 reacted with fifty-six proteins on the protein macroarray membrane. One of these new proteins, Limkain B (LMKB), was chosen for further study because it was previously reported to localize to a “subset of peroxisomes”, a staining pattern that might appear similar to the P-body pattern. Antibodies in serum 0081 reacted with glutathione S-transferase (GST)-LMKB, but not GST alone, by immunoblot. A plasmid encoding full-length LMKB fused to GFP was used to express the protein in HEp-2 cells. LMKB localized to cytoplasmic dots and co-localized with Ge-1, a known P-body component.

Conclusion: Our findings demonstrate that the combination of proteomic array technology and human autoantibodies provides a useful tool for identifying new autoantigens. “Autoantigenomics” can be used to rapidly and efficiently discover new proteins in cellular structures. Using this method, we identified LMKB as a novel component of mRNA processing bodies.


Disclosure:

W. H. Yang,
None;

E. G. Bloch,
None;

D. F. Berenson,
None;

R. L. Galdos,
None;

P. Arora,
None;

C. Wu,
None;

D. B. Bloch,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-use-of-autoantigenomics-to-rapidly-identify-targets-of-human-autoantibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences